Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.45 |
| ▸ | AHR | P35869 | 7/20 | 0.43 |
| ▸ | TTR | P02766 | 2/20 | 0.41 |
| ▸ | PRKDC | P78527 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.35 |
| ▸ | MAOA | P21397 | 2/20 | 0.35 |
| ▸ | MAOB | P27338 | 2/20 | 0.35 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25818436 | 0.89 | ALOX5 (0.45) | ALOX5AHRTTRALDH1A1MAPK1 | |
| SCHEMBL25567683 | 0.86 | ALOX5 (0.47) | ALOX5AHRTTRPRKDCDYRK1A | |
| SCHEMBL24969295 | 0.81 | TTR (0.49) | ALOX5AHRTTRPRKDCDYRK1A | |
| SCHEMBL22129987 | 0.81 | AHR (0.54) | ALOX5AHRTTRPRKDCALDH1A1 | |
| SCHEMBL29693288 | 0.81 | TTR (0.49) | ALOX5AHRTTRPRKDCDYRK1A | |
| SCHEMBL16491686 | 0.81 | AHR (0.49) | ALOX5AHRPRKDCALDH1A1MAPK1 | |
| SCHEMBL25567903 | 0.80 | ALOX5 (0.48) | ALOX5AHRTTRPRKDCALDH1A1 | |
| SCHEMBL23765006 | 0.80 | AHR (0.45) | ALOX5AHRTTRALDH1A1MAOA | |
| SCHEMBL22117396 | 0.77 | AHR (0.51) | AHRTTRDYRK1AMAOA | |
| SCHEMBL29976750 | 0.77 | AHR (0.51) | AHRTTRDYRK1AMAOA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217825-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-07-06 | — | — | US | disclosed |
| US-20230217825-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230217825-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | OR10J3, AOC2, EPCAM | ALOX5 693/4885AHR 3212/4885TTR 2393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.